IFP Advisors, Inc - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2017. The put-call ratio across all filers is 319.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q4 2018$0100.0%0.00%
Q3 2018$0100.0%0.00%
Q2 2018$0100.0%0.00%
Q1 2018$0100.0%0.00%
Q4 2017$0
-100.0%
10
-97.2%
0.00%
Q3 2017$2,000
+100.0%
3600.0%0.00%
Q2 2017$1,0000.0%3600.0%0.00%
Q1 2017$1,0000.0%3600.0%0.00%
Q4 2016$1,000360
+3500.0%
0.00%
Q3 2016$010
-90.9%
0.00%
Q2 2016$01100.0%0.00%
Q4 2015$01100.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders